Who makes F-18 Fluoro-deoxi-glucose?

F-18 Fluoro-deoxi-glucose is developed by Stanford University.

What development phase is F-18 Fluoro-deoxi-glucose in?

F-18 Fluoro-deoxi-glucose is in Phase 1.

Last reviewed 2026-04-20 · How we verify

F-18 Fluoro-deoxi-glucose

Stanford University · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	F-18 Fluoro-deoxi-glucose
Also known as	fluorodeoxyglucose (18F), Fludeoxyglucose (18F), 18F-FDG, FDG
Sponsor	Stanford University
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

F-18 Fluoro-deoxi-glucose CI brief — competitive landscape report
F-18 Fluoro-deoxi-glucose updates RSS · CI watch RSS
Stanford University portfolio CI